Cerebrospinal Fluid Leak D065634

Related MeSH Hierarchy (4)

Diseases [C] » Nervous System Diseases [C10] » Neurologic Manifestations » Cerebrospinal Fluid Leak

Diseases [C] » Nervous System Diseases [C10] » Trauma, Nervous System » Craniocerebral Trauma » Cerebrospinal Fluid Leak

Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Neurologic Manifestations » Cerebrospinal Fluid Leak

Diseases [C] » Wounds and Injuries [C26] » Trauma, Nervous System » Craniocerebral Trauma » Cerebrospinal Fluid Leak

Description

Discharge of cerebrospinal fluid through a hole through the skull bone most commonly draining from the nose (CEREBROSPINAL FLUID RHINORRHEA) or the ear (CEREBROSPINAL FLUID OTORRHEA).   MeSH

Subtype Terms (2)

Cerebrospinal Fluid Otorrhea
7 drugs (6 approved, 1 experimental)


Phase 4 Indicated Drugs (2)

Phase 3 Indicated Drugs (1)

Phase 2 Indicated Drugs (1)

Other Experimental Indicated Drugs (2)


Organization Involved with Phase 4 Indications (2)

Organization Involved with Phase 3 Indications (1)

Organization Involved with Phase 2 Indications (2)

Organization Involved with Other Experimental Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.